Stock listing

NASDAQ:LJPC La Jolla Pharmaceutical Co Stock

Follow La Jolla Pharmaceutical Co into a list and get an email when it puts out news.

Last close · NASDAQ:LJPC

$6.22 USD

Close on Aug 22, 2022 · No longer trades

Jan 29, 2014 to last close -23.2% · weekly closes, Jan 29, 2014 – Aug 22, 2022
Lowest – highest close
$2.42 – $43.90 USDSince Jan 29, 2014 · lowest Nov 26, 2019 · highest Sep 8, 2015

Delisted NASDAQ:LJPC no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:LJPC
Asset type
Stock
Exchange
NASDAQ
Currency
USD

La Jolla Pharmaceutical Co on 6ix

Decks
13 decks · latest Dec 29, 2017

Decks

DeckKindSlidesDate
Investor Presentation (December 2017)Investor deck13 slidesDec 29, 2017
Investor Presentation (April 2017)Investor deck36 slidesApr 11, 2017
Technical Presentation (February 2017)Technical16 slidesFeb 28, 2017
Investor Presentation (September 2016)Investor deck34 slidesSep 19, 2016
Technical Presentation (September 2016)Technical9 slidesSep 8, 2016
Investor Presentation (January 2016)Investor deck33 slidesJan 11, 2016
Investor Presentation (July 2015)Investor deck17 slidesJul 27, 2015
Investor Presentation (July 2015)Investor deck31 slidesJul 27, 2015
Investor Presentation (October 2014)Investor deck38 slidesOct 14, 2014
Investor Presentation (July 2014)Investor deck37 slidesJul 22, 2014
All 13 decks
DeckKindSlidesDate
Investor Presentation (May 2013)Investor deck40 slidesMay 16, 2013
Investor Presentation (February 2013)Investor deck51 slidesFeb 4, 2013
RetailInvestorConferences.com Live Webcast (July 2012)Conference27 slidesJul 13, 2012

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Craig Johnson
Other companies: Aurinia Pharmaceuticals Inc (Board Director · Since at least Nov 7, 2024); Heron Therapeutics, Inc. (Lead Independent Director · Since at least Jan 10, 2014); PURE Bioscience (Chief Financial Officer · Aug 1, 2011 – Aug 1, 2011 · Past); DMK Pharmaceuticals Corporation (Director · Feb 10, 2011 – Oct 16, 2013 · Past); Ardea Biosciences Inc (Director · Jan 3, 2011 – Jun 19, 2012 · Past)
Director · Oct 14, 2013 – Aug 22, 2022 · Past
Kevin Tang
Other companies: Aurinia Pharmaceuticals Inc (Chief Executive Officer, Director · Since at least Sep 12, 2024); Jounce Therapeutics Inc (Director · May 3, 2023 – May 3, 2023 · Past); Heron Therapeutics, Inc. (Director · Dec 22, 2015 – Dec 31, 2019 · Past)
Director · Aug 19, 2015 – Aug 22, 2022 · Past
David Ramsay
Other companies: Halozyme Therapeutics, Inc. (President, Drug Delivery · Since at least Mar 23, 2026); Savara, Inc. (Director · Since at least Jun 19, 2019)
Director · Oct 8, 2019 – Aug 22, 2022 · Past
Robert Rosen
Other companies: ImmunityBio, Inc. (Director · Jul 27, 2015 – Jul 27, 2015 · Past); Heron Therapeutics, Inc. (President, Director · May 1, 2013 – Dec 15, 2018 · Past)
Director · Jul 7, 2014 – Aug 22, 2022 · Past
Saiid Zarrabian
Other companies: TuHURA Biosciences, Inc. (Head of Strategic Partnerships, Director · Jul 7, 2017 – Dec 6, 2021 · Past); Penwest Pharmaceuticals Co (Director · Jun 30, 2010 – Sep 20, 2010 · Past)
Director · Jan 19, 2012 – May 14, 2015 · Past
James Rolke
Other companies: Revelation Biosciences, Inc. (Chairman, Director and Chief Executive Officer · Since at least Jan 10, 2022)
Chief Scientific Officer · Jan 1, 2017 – May 29, 2020 · Past
Larry G Edwards
Other companies: Innoviva, Inc. (CEO of La Jolla Pharmaceutical · Aug 22, 2022 – Aug 22, 2022 · Past)
Chief Executive Officer, Director · Dec 10, 2020 – Aug 22, 2022 · Past
Laura L Johnson
Other companies: TuHURA Biosciences, Inc. (Director · Jun 26, 2020 – Aug 30, 2023 · Past)
Director · Oct 14, 2013 – Aug 22, 2022 · Past
Michael Hearne
Other companies: Aurinia Pharmaceuticals Inc (Chief Financial Officer · Since at least Mar 23, 2026)
Officer · Jun 1, 2020 – Aug 22, 2022 · Past
Teddi ReillyVP of Human Resources · Dec 31, 2005 – Mar 31, 2006 · Past

Open People

Log in to ask 6ix AI your own questions about La Jolla Pharmaceutical Co.